Orgenesis Inc. (ORGS)
OTCMKTS
· Delayed Price · Currency is USD
1.690
+0.300 (21.58%)
Jan 21, 2025, 4:00 PM EST
Orgenesis Employees
Orgenesis had 146 employees as of December 31, 2023. The number of employees decreased by 21 or -12.57% compared to the previous year.
Employees
146
Change (1Y)
-21
Growth (1Y)
-12.57%
Revenue / Employee
$6,158
Profits / Employee
-$235,699
Market Cap
8.74M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Endo Inc. | 2,931 |
Elite Pharmaceuticals | 64 |
Glass House Brands | 413 |
Northwest Biotherapeutics | 25 |
Silence Therapeutics | 109 |
SANUWAVE Health | 31 |
Orgenesis News
- 2 months ago - Orgenesis GAAP EPS of $1.93, revenue of $0.3M - Seeking Alpha
- 4 months ago - Why Orgenesis (ORGS) Stock Is Down 23% Today - Benzinga
- 4 months ago - Orgenesis announces 1-for-10 reverse stock split to regain Nasdaq compliance - Seeking Alpha
- 5 months ago - Orgenesis Announces Positive Results From a Real-World Study of ORG-101 CAR-T Therapy in Patients with CD19+ Acute Lymphoblastic Leukemia - GlobeNewsWire
- 5 months ago - Orgenesis Announces Strategic Partnership with Harley Street Healthcare Group to Launch a State-of-the-Art Longevity & Wellness Initiative Globally - GlobeNewsWire
- 8 months ago - Orgenesis Provides Business Update for the First Quarter of 2024 - GlobeNewsWire
- 10 months ago - Orgenesis Provides Year End Business Update - GlobeNewsWire
- 10 months ago - Germfree and Orgenesis Announce Asset Purchase and Strategic Partnership Intended to Revolutionize Cell and Gene Therapy Through Decentralized Production and Global Accessibility - GlobeNewsWire